Eli Lilly Says Its New Weight-Loss Drug, Zepbound, Is Now Available
Tirzepatide, the active ingredient in Zepbound, had already been approved by the FDA as a treatment for type 2 diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.